1 | DEXMEDETOMIDINE | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [14] 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
2 | Dexmedetomidine 1 | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
3 | Dexmedetomidine 2 | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
4 | Dexmedetomidine 3 | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
5 | Dexmedetomidine group | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
6 | Dexmedetomidine Hcl 100 Mcg/mL Inj | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 215 215 💬
|
7 | DEXMEDETOMIDINE HYDROCHLORIDE | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
8 | Dexmedetomidine Hydrochloride Infusion | [1] Dexmedetomidine Dexmedetomidine | [1] Dexmedetomidine
Dexmedetomidine
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
9 | Dexmedetomidine with ropivacaine | [2] Dexmedetomidine Dexmedetomidine, Ropivacaine | [2] Dexmedetomidine
Dexmedetomidine
,
Ropivacaine
💬
| [8] ADRA2A ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
10 | Fentanyl (Low Dose) + Dexmedetomidine | [2] Dexmedetomidine Dexmedetomidine, Fentanyl | [2] Fentanyl
Fentanyl
,
Dexmedetomidine
💬
| [4] ADRA2A ADRA2A, ADRA2B, ADRA2C, OPRM1 💬
| [4] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 215 215 💬
|
11 | Scopolamine, atropine, edaravone and dexmedetomidine | [4] Atropine Atropine, Dexmedetomidine, Edaravone, Scopolamine | [4] Atropine
Atropine
,
Scopolamine
,
Dexmedetomidine
,
Edaravone
💬
| [8] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 💬
|